A Russian company has developed an innovative medical exoskeleton to maintain an upright posture and improve patient mobility and self-care. For medical institutions, hospitals, rehabilitation centers - a 5 year exclusive license is offered for the exoskeleton production technology know-how. The company is looking for reliable partners to conclude a license agreement.
The Russian company from Moscow specializes in the development of technological know-how in the medical field. The Russian company has developed an innovative medical exoskeleton. The exoskeleton is produced in two types: basic and with biofeedback from the biopotentials of the brain or neuromuscular activity by electromyography (EMG). Designed for patients with a height of 1.4 m to 1.9 m and a weight of 40 to 100 kg. Exoskeleton weight is 20 kg. In the future, the weight will be reduced to 15 kg. The time of continuous operation on one battery when walking at a speed of 0.5 km / h is at least 4 hours. EMG electrodes are attached to the skin over the flexor muscles of the thigh or lower leg. The probability of true EMG identification of large muscle movements is 86-87% with pattern lengths from 50 to 200 ms. The exoskeleton can be controlled remotely or by the patient himself. The remote control is a tablet with software. Wireless control of the exoskeleton (up to 50 m) gives the ability to monitor, configure parameters for training, as well as display visual information with the preservation of training results in the patient database. Control of the exoskeleton by the patient is possible with the help of a smartwatch with software. The patient can independently control the product, choose different training parameters. The exoskeleton is designed for use in clinics, treatment and rehabilitation centers, and hospitals. Since the exoskeleton is fully adapted to the anthropological parameters of the patient, this contributes to the more effective restoration of the muscle tone of the lower extremities. This product is designed for the treatment, training, and rehabilitation of patients with injuries and diseases of the musculoskeletal system and nervous system that lead to impaired movement of the lower extremities. The exoskeleton allows reproduce the usual manner of walking with the use of elbow crutches, overcome low obstacles and walk on steps. Successful tests were carried out. The Russian company is looking for foreign partners from the medical field for long-term relationships and to conclude a license agreement. The license includes documentation (design, technical and operational, industrial regulations for the manufacture, test response); software for the exoskeleton and for control panels; prototype of the exoskeleton, control panels, accessories, rechargeable batteries, elbow crutch, biofeedback electromyography system. Under this license agreement, the foreign partner will receive an exclusive license for the know-how of the production technology of the exoskeleton of the Russian company. Detailed information on the license configuration, terms of delivery and support, as well as a list of equipment required for production and technical requirements for materials will be provided upon request.
Type (e.g. company, R&D institution…), field of industry and Role of Partner Sought:
Type: SMEs, large hospitals, rehabilitation centers. Role of a partner: Licensee will buy and receive an exclusive license for 5years for the Exoskeleton production technology, for full-fledged own production. License agreement is concluding with developer’s official representative in the EU.
Stage of Development:
Already on the market